EP1516042B1 - Foam disinfectant - Google Patents

Foam disinfectant Download PDF

Info

Publication number
EP1516042B1
EP1516042B1 EP03738067A EP03738067A EP1516042B1 EP 1516042 B1 EP1516042 B1 EP 1516042B1 EP 03738067 A EP03738067 A EP 03738067A EP 03738067 A EP03738067 A EP 03738067A EP 1516042 B1 EP1516042 B1 EP 1516042B1
Authority
EP
European Patent Office
Prior art keywords
foam
disinfectant
mentioned
antimicrobial agent
atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP03738067A
Other languages
German (de)
French (fr)
Other versions
EP1516042A1 (en
Inventor
Holger Biering
Michael Decker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ecolab Inc
Original Assignee
Ecolab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ecolab Inc filed Critical Ecolab Inc
Publication of EP1516042A1 publication Critical patent/EP1516042A1/en
Application granted granted Critical
Publication of EP1516042B1 publication Critical patent/EP1516042B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005Other compounding ingredients characterised by their effect
    • C11D3/0094High foaming compositions
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/88Ampholytes; Electroneutral compounds
    • C11D1/94Mixtures with anionic, cationic or non-ionic compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2003Alcohols; Phenols
    • C11D3/2006Monohydric alcohols
    • C11D3/201Monohydric alcohols linear
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2003Alcohols; Phenols
    • C11D3/2006Monohydric alcohols
    • C11D3/2017Monohydric alcohols branched
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/38Cationic compounds
    • C11D1/40Monoamines or polyamines; Salts thereof
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/38Cationic compounds
    • C11D1/52Carboxylic amides, alkylolamides or imides or their condensation products with alkylene oxides
    • C11D1/528Carboxylic amides (R1-CO-NR2R3), where at least one of the chains R1, R2 or R3 is interrupted by a functional group, e.g. a -NH-, -NR-, -CO-, or -CON- group
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/38Cationic compounds
    • C11D1/62Quaternary ammonium compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/662Carbohydrates or derivatives
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/72Ethers of polyoxyalkylene glycols
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/88Ampholytes; Electroneutral compounds
    • C11D1/90Betaines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention relates to an aqueous foam disinfectant comprised of a special surfactant system, which consists of non-ionic and amphoteric surfactants, and of a synergistic disinfectant constituent, which consists of an antimicrobial agent having amino groups and of at least one additional antimicrobial agent.

Description

Gegenstand der vorliegenden Erfindung sind wässerige Schaumdesinfektionsmittel, umfassend ein zur Schaumbildung befähigtes Tensidsystem aus nichtionischen und amphoteren Tensiden sowie eine synergistische Desinfektionsmittel-kombination. Als weiteren Gegenstand enthält die vorliegende Erfindung ein Verfahren zur Schaumdesinfektion von Oberflächen unter Zuhilfenahme einer schaumerzeugenden Vorrichtung sowie die Verwendung der erfindungsgemäßen Schaumdesinfektionsmittel zur Desinfektion von Oberflächen.The present invention relates to aqueous foam disinfectants comprising a foam system capable of surfactant system of nonionic and amphoteric surfactants and a synergistic disinfectant combination. As a further object, the present invention contains a method for foam disinfection of surfaces with the aid of a foam-producing device and the use of the foam disinfectant according to the invention for the disinfection of surfaces.

Die Verwendung von Zusammensetzungen, die in Form eines Schaums auf Oberflächen aufgebracht werden, ist bereits in verschiedenen Dokumenten beschrieben. Ein Beispiel hierfür ist die deutsche Anmeldung DE 20 01 317.The use of compositions which are applied to surfaces in the form of a foam has already been described in various documents. An example of this is the German application DE 20 01 317.

In den meisten Fällen des Stands der Technik enthalten die entsprechenden Formulierungen anionische Tenside, wie beispielsweise Natriumlaurylsulfat, Natriumdodecylbenzolsulfonat, Natriumsalze von Laurylsaccosinat und in einigen Fällen Tenside, die die Stabilität des Schaums weiter verbessern, wie beispielsweise Lauryldiethanolamid. Der wesentliche Vorteil von schaumbildenden Formulierungen besteht darin, dass diese im Vergleich zu anderen Formulierungen wesentlich effektiver hinsichtlich der Reinigung und Desinfektion von Oberflächen eingesetzt werden können. Dies liegt in erster Linie an der besseren Benetzung, insbesondere von nicht horizontalen Oberflächen. Dadurch wird erreicht, dass die Mittel längere Zeit an der Oberfläche haften und demzufolge aufgrund der längeren Kontaktzeit der Desinfektionseffekt vergrößert wird. Ein weiterer Vorteil von schaumbildenden Formulierungen besteht darin, dass beim Versprühen Tropfen in einer Größe entstehen, welche aufgrund ihrer Dimension keine relevante inhalative Exposition erwarten lassen. Dies ist insbesondere von Bedeutung bei der Verwendung von Mikrobiziden oder anderen Rezepturbestandteilen, welche potentiell reizende oder ätzende Eigenschaften haben. Die üblicherweise eingesetzten Tensidsysteme sind jedoch nicht in allen Formulierungen gleichermaßen verwendbar. Insbesondere sind anionische Tenside, wenn es darum geht, in Formulierungen mit aminischen oder kationischen Bioziden formuliert zu werden, nicht günstig aufgrund von möglichen Ausfällungen.In most prior art formulations, the corresponding formulations contain anionic surfactants such as sodium lauryl sulfate, sodium dodecylbenzenesulfonate, sodium salts of laurylsaccosinate and, in some instances, surfactants which further enhance the stability of the foam, such as lauryldiethanolamide. The main advantage of foam-forming formulations is that they can be used much more effectively with respect to the cleaning and disinfection of surfaces compared to other formulations. This is primarily due to the better wetting, especially of non-horizontal surfaces. This ensures that the agent adhere to the surface for a longer time and therefore is increased due to the longer contact time of the disinfecting effect. A further advantage of foam-forming formulations is that during spraying drops of a size are formed which, due to their size, do not allow for any relevant inhalative exposure. This is particularly important in the use of microbicides or other formulation ingredients that have potentially irritating or corrosive properties. However, the surfactant systems commonly used are not equally useful in all formulations. In particular, when it comes to formulating formulations with aminic or cationic biocides, anionic surfactants are not benign because of possible precipitations.

Dem Fachmann ist einerseits bekannt, dass langkettige Fettamine und ihre Salze sowie aliphatische Diamine sehr wirksame Mikrobizide mit breitem Wirkungsspektrum sind.On the one hand, it is known to the person skilled in the art that long-chain fatty amines and their salts as well as aliphatic diamines are very effective microbicides with a broad spectrum of activity.

So beschreibt beispielsweise das US Patent 5,856,290 eine Reinigerzusammensetzung für harte Oberflächen, die ein entsprechendes Desinfektionsmittel enthält, und die darüber hinaus durch Zugabe einer Mischung aus Alkyl- oder Alkenyloligoglycosid und bestimmten C8-C18-Alkylethern eine gesteigerte Wirksamkeit bei der Verringerung der Bakterienzahl aufweist.For example, US Pat. No. 5,856,290 describes a hard surface cleaner composition containing a corresponding disinfectant which moreover has enhanced bacterial reduction efficiency by addition of a mixture of alkyl or alkenyl oligoglycoside and certain C 8 -C 18 alkyl ethers ,

Darüber hinaus beschreibt die DE 196 15 286 A1 antimikrobielle Wirkstoffkonzentrate, die a) Amidierungsprodukte von N-substituierten Propylendiaminen mit 2-Aminoglutarsäureestern und b) Esterquats enthalten. Die Mittel besitzen eine synergistische Leistungsverstärkung bei der Abtötung von Mikroorganismen.In addition, DE 196 15 286 A1 describes antimicrobial active substance concentrates which comprise a) amidation products of N-substituted propylenediamines with 2-aminoglutaric acid esters and b) esterquats. The agents have a synergistic performance enhancement in the killing of microorganisms.

Andererseits ist es in der Praxis auch bekannt, dass der Einsatz von aminischen Bioziden zur Sensibilisierung von Hautoberflächen führen kann. Dies drückt sich durch Rötungen in den mit den Aminen in Kontakt gekommenen Haut-Bereichen aus.
Auch die Ökotoxizität derartiger Amine stellt häufig einen Nachteil dar. Bei allzu hohen Konzentrationen kann es sogar dazu kommen, dass, je nach Umständen, die Mikroflora der jeweiligen Kläranlage empfindlich gestört wird. Deshalb war es ein Ziel der vorliegenden Erfindung aminische Mikrobizide so zu formulieren und anzuwenden, dass möglichst geringe Mengen erforderlich sind.
On the other hand, it is also known in practice that the use of amine biocides can lead to sensitization of skin surfaces. This is expressed by redness in the skin areas in contact with the amines.
The ecotoxicity of such amines is often a disadvantage. At too high concentrations, it may even happen that, depending on the circumstances, the microflora of each wastewater treatment plant is severely disturbed. It was therefore an object of the present invention to formulate and apply aminic microbicides in such a way that the smallest possible amounts are required.

Dementsprechend beschäftigte sich die vorliegende Erfindung in erster Linie damit, neue Kombinationen aus zur Schaumbildung befähigten Tensidsystemen und aminischen Bioziden in Kombination mit weiteren antimikrobiellen Wirkstoffen zu finden.Accordingly, the present invention was primarily concerned with finding new combinations of foamable surfactant systems and amine biocides in combination with other antimicrobial agents.

Gegenstand der vorliegenden Erfindung sind Schaumdesinfektionsmittel, umfassend 0,1 bis 10 Gew.-% eines in Kontakt mit Aminen zur Schaumbildung befähigten Tensidsystems aus nichtionischen und amphoteren Tensiden sowie eine synergistische Desinfektionsmittel-Kombination bestehend aus einem antimikrobiellen Wirkstoff mit Amino-Gruppen und zumindest einem weiteren antimikrobiellen Wirkstoff.The present invention provides foam disinfectants comprising from 0.1 to 10% by weight of a surfactant system comprising nonionic and amphoteric surfactants capable of foaming in contact with amines, and a synergistic disinfectant combination consisting of an antimicrobial agent having amino groups and at least one other antimicrobial agent.

Vorzugsweise sind darunter Schaumdesinfektionsmittel zu verstehen, die als Tensidsystem nichtionische Tenside, ausgewählt aus den Gruppen der Fettalkoholethoxylate und Alkylpolyglycoside, und amphotere Tenside, ausgewählt aus der Gruppe der Acetobetaine, enthalten.These are preferably to be understood as meaning foam disinfectants which contain nonionic surfactants selected from the groups of the fatty alcohol ethoxylates as surfactant system and alkylpolyglycosides, and amphoteric surfactants selected from the group of acetobetaines.

Ganz besonders bevorzugt ist, wenn das genannte Tensidsystem mindestens je ein Tensid aus den Gruppen der Fettalkoholethoxylate, Alkylpolyglycoside und Acetobetaine enthält.It is very particularly preferred if the said surfactant system contains at least one surfactant each from the groups of fatty alcohol ethoxylates, alkylpolyglycosides and acetobetaines.

Dabei ist es bevorzugt, wenn die genannten Tensidgruppen der Fettalkoholethoxylate, Alkylpolyglykoside und Acetobetaine zueinander in einem Gewichts-Mengen-Verhältnis von (5 bis 7) zu (2 bis 4) zu (0,5 bis 1,5) vorliegen.It is preferred if the said surfactant groups of the fatty alcohol ethoxylates, alkyl polyglycosides and acetobetaines to each other in a weight-amount ratio of (5 to 7) to (2 to 4) to (0.5 to 1.5).

Im Hinblick auf das aminhaltige Mikrobizid enthält das erfindungsgemäße Schaumdesinfektionsmittel vorzugsweise einen antimikrobiellen Wirkstoff mit Amino-Gruppen in einer Menge von insgesamt 0,001 bis 10 Gew.-%, bezogen auf das gesamte Mittel.With regard to the amine-containing microbicide, the foam disinfectant of the present invention preferably contains an antimicrobial agent having amino groups in an amount of 0.001 to 10% by weight in total, based on the whole agent.

Dabei hat es sich als besonders vorteilhaft herausgestellt, wenn der genannte antimikrobielle Wirkstoff mit Amino-Gruppen ausgewählt ist aus Alkylaminen der Formel (I) und/oder (II)

        R1-NH-(CH2)3NH2     (I),

        R1-N-[(CH2)3NH2]2     (II),

die unneutralisiert, teilweise oder vollständig neutralisiert vorliegen können, wobei R1 für einen Alkylrest mit 8 bis 18 C-Atomen, vorzugsweise 12 bis 14 C-Atomen, steht, und/oder
Wirkstoffen, die durch Umsetzung eines Propylendiamins gemäß Formel (I),

        R1-NH-(CH2)3NH2     (I),

mit Glutaminsäure oder Glutaminsäurederivaten gemäß Formel (III),

        R2-O-CO-(CH2)2-CH(NH2)-COOH     (III),

in der R2 Wasserstoff oder einen Alkylrest mit 1 bis 4 Kohlenstoffatomen bedeutet, und gegebenenfalls Umsetzung des so erhaltenen Produkts mit Ethylenoxid und/oder Propylenoxid und gegebenenfalls weitere Umsetzung mit organischen oder anorganischen Säuren erhältlich sind.
It has been found to be particularly advantageous when said antimicrobial agent having amino groups is selected from alkylamines of the formula (I) and / or (II)

R 1 is -NH- (CH 2 ) 3 NH 2 (I),

R 1 -N - [(CH 2 ) 3 NH 2 ] 2 (II),

which may be unneutralized, partially or completely neutralized, wherein R 1 is an alkyl radical having 8 to 18 C-atoms, preferably 12 to 14 C-atoms, and / or
Active substances obtained by reacting a propylenediamine of the formula (I),

R 1 is -NH- (CH 2 ) 3 NH 2 (I),

with glutamic acid or glutamic acid derivatives according to formula (III),

R 2 is -O-CO- (CH 2 ) 2 -CH (NH 2 ) -COOH (III),

in which R 2 is hydrogen or an alkyl radical having 1 to 4 carbon atoms, and optionally reaction of the product thus obtained with ethylene oxide and / or propylene oxide and optionally further reaction with organic or inorganic acids are obtainable.

Wie einleitend bereits ausgeführt, sind aminhaltige Mikrobizide nicht problemlos einsetzbar.
Zur Überwindung von Nachteilen wird das erfindungsgemäße Schaumdesinfektionsmittel mit zumindest einem weiteren antimikrobiellen Wirkstoff, vorzugsweise ausgewählt aus der Gruppe der einwertigen niedermolekularen Alkohole gemäß Formel (IV),

Figure imgb0001
in der R3, R4 und R5 unabhängig voneinander H-Atome oder Alkylreste mit jeweils 1 bis 3 C-Atomen umfassen, wobei die Gesamtzahl der C-Atome nicht größer als 6 ist, kombiniert.As stated in the introduction, amine-containing microbicides are not easily used.
To overcome disadvantages, the foam disinfectant according to the invention with at least one further antimicrobial active ingredient, preferably selected from the group of monohydric low molecular weight alcohols according to formula (IV),
Figure imgb0001
in which R 3 , R 4 and R 5 independently of one another comprise H atoms or alkyl radicals having in each case 1 to 3 C atoms, the total number of C atoms being not greater than 6, combined.

Es ist hervorzustellen, dass die Aufgabe besonders gut gelöst wird, wenn das erfindungsgemäße Schaumdesinfektionsmittel einen Alkohol ausgewählt aus Ethanol, 1-Propanol und 2-Propanol oder Mischungen derselben enthält, wobei der Gesamtgehalt an Alkoholen, bezogen auf das gesamte Mittel, vorzugsweise insgesamt 20 bis 50 Gew.-% ausmacht, besonders bevorzugt 20 bis 40 Gew.-%. Dabei sind die gewünschte Schaumbildung und Schaumstabilität besonders gut ausgeprägt, wenn Ethanol und/oder i-Propanol in dem Schaumdesinfektionsmittel vorliegen.It should be noted that the object is achieved particularly well if the foam disinfectant according to the invention contains an alcohol selected from ethanol, 1-propanol and 2-propanol or mixtures thereof, wherein the total content of alcohols, based on the total agent, preferably a total of 20 to 50 wt .-% makes, more preferably 20 to 40 wt .-%. The desired foaming and foam stability are particularly pronounced when ethanol and / or i-propanol are present in the foam disinfectant.

Selbstverständlich ist es ebenfalls möglich, dass das erfindungsgemäße Schaumdesinfektionsmittel als antimikrobiellen Wirkstoff neben oder statt des genannten Alkohols eine andere antimikrobielle Komponente, ausgewählt aus den Gruppen der Alkohole, die nicht unter Formel (IV) fallen, der antimikrobiellen Säuren, Carbonsäureester, Säureamide, Phenole, Phenolderivate, Diphenyle, Diphenylalkane, Harnstoffderivate, Sauerstoff-, Stickstoff-Acetale sowie -Formale, Benzamidine, Isothiazoline, Phthalimidderivate, Pyridinderivate, antimikrobiellen oberflächenaktiven Verbindungen, Guanidine, antimikrobiellen amphoteren Verbindungen, Chinoline, 1,2-Dibrom-2,4-dicyanobutan, lodo-2-propynyl-butyl-carbamat, lod, lodophore, wobei insbesondere Undecylensäure, Zitronensäure, 2-Benzyl-4-chlorphenol, 2,2'-Methylen-bis-(6-brom-4-chlorphenol), 2,4,4'-Trichlor-2'-hydroxydiphenylether, N-(4-Chlorphenyl)-N-(3,4-dichlorphenyl)-hamstoff, N,N'-(1,10-decandiyldi-1-pyridinyl-4-yliden)-bis-(1-octanamin)-dihydrochlorid, N,N'-Bis-(4-Chlorphenyl)-3,12-diimino-2,4,11,13-tetraaza-tetradecandiimidamid, quaternäre Ammoniumverbindungen, Guanidine, Amphotere in Frage kommen, zu formulieren.Of course, it is also possible that the foam disinfectant according to the invention as antimicrobial active ingredient next to or instead of said alcohol, another antimicrobial component selected from the groups of alcohols not falling under formula (IV), the antimicrobial acids, carboxylic acid esters, acid amides, phenols, Phenol derivatives, diphenyls, diphenylalkanes, urea derivatives, oxygen, nitrogen acetals and formals, benzamidines, isothiazolines, phthalimide derivatives, pyridine derivatives, antimicrobial surface-active compounds, guanidines, antimicrobial amphoteric compounds, quinolines, 1,2-dibromo-2,4-dicyanobutane, iodo-2-propynyl-butyl-carbamate, iodine, iodophores, in particular undecylenic acid, citric acid, 2-benzyl-4-chlorophenol, 2,2'-methylenebis (6-bromo-4-chlorophenol), 2,4 , 4'-Trichloro-2'-hydroxydiphenyl ether, N- (4-chlorophenyl) -N- (3,4-dichlorophenyl) -urea, N, N '- (1,10-decanediyldi-1-pyridinyl-4-ylidene ) -bis- (1-octanamine) - dihydrochloride, N, N'-bis (4-chlorophenyl) -3,12-diimino-2,4,11,13-tetraaza-tetradecandiimidamide, quaternary ammonium compounds, guanidines, amphoteric agents.

Hervorzuheben sind in diesem Zusammenhang quaternäre Ammoniumverbindungen, wie auch in den Beispielen (E1) zum Ausdruck kommt.Of particular note in this context are quaternary ammonium compounds, as also expressed in Examples (E1).

Vorzugsweise enthält das erfindungsgemäße Schaumdesinfektionsmittel, bezogen auf das gesamte Mittel,
0,005 bis 2,0 Gew.-% des genannten antimikrobiellen Wirkstoffs mit Amino-Gruppen und
20 bis 40 Gew.-% der genannten Alkohole gemäß Formel IV oder deren Mischungen und
0,5 bis 5 Gew.-% des genannten Tensidsystems, sowie
0 bis 6 Gew.-% übliche Zusatzstoffe wie Komplexbildner und Parfüm
und gewünschtenfalls als Rest auf 100 Gew.-% Wasser und/oder sonstige übliche Hilfs- und Zusatzstoffe.
Preferably, the foam disinfectant according to the invention contains, based on the total agent,
0.005 to 2.0 wt .-% of said antimicrobial agent with amino groups and
20 to 40 wt .-% of said alcohols according to formula IV or mixtures thereof and
0.5 to 5 wt .-% of said surfactant system, and
0 to 6 wt .-% of conventional additives such as complexing agents and perfume
and, if desired, the remainder to 100% by weight of water and / or other customary auxiliaries and additives.

Ein weiterer Gegenstand der vorliegenden Erfindung ist ein Verfahren zur Schaumdesinfektion von Oberflächen, bei dem ein erfindungsgemäßes Schaumdesinfektionsmittel unter Zuhilfenahme einer schaumerzeugenden Vorrichtung, beispielsweise einer Schaumsprühflasche, auf die genannten Oberflächen in Form eines Schaums aufgebracht wird, wobei der Schaum gewünschtenfalls nach ausreichender Einwirkzeit durch Abspülen mit Wasser oder Abwischen mit textilem Gewebe wieder entfernt wird.Another object of the present invention is a method for foam disinfection of surfaces, in which a foam disinfectant according to the invention is applied with the aid of a foam-generating device, such as a foam spray bottle on said surfaces in the form of a foam, wherein the foam, if desired after sufficient exposure time by rinsing with Water or wiping with textile fabric is removed again.

Ebenso ist ein Gegenstand der vorliegenden Erfindung, die Verwendung der erfindungsgemäßen Schaumdesinfektionsmittel zur Desinfektion von Oberflächen.Likewise an object of the present invention is the use of the foam disinfectant according to the invention for the disinfection of surfaces.

Dabei hat sich die erfindungsgemäße Verwendung als besonders nützlich bei der Desinfektion von Oberflächen im medizinischen Bereich, in der Lebensmittel herstellenden und/oder verarbeitenden Industrie, im Hotelgewerbe, in öffentlichen Gebäuden und Institutionen erwiesen.In this case, the use according to the invention has proved to be particularly useful in the disinfection of surfaces in the medical field, in the food-producing and / or processing industry, in the hotel industry, in public buildings and institutions.

Bei der Ausprobung der erfinderischen Desinfektionsmittel hat sich als ein Vorteil gezeigt, dass die erfindungsgemäßen Formulierungen bei ausreichender antimikrobieller Wirksamkeit und trotz des hohen Alkohol-Gehalts in der Anwendung einen stabilen Schaum bilden. Hinzu kommt, daß nach der Anwendung die Oberflächen innerhalb sehr kurzer Zeit wieder trocken sindIn the trial of the inventive disinfectants has proven to be an advantage that the formulations according to the invention with sufficient antimicrobial activity and despite the high alcohol content in the application form a stable foam. In addition, after application, the surfaces are dry again within a very short time

BEISPIELEEXAMPLES 1. Herstellung von Testlösungen1. Preparation of test solutions

Durch einfaches Zusammenfügen verschiedener Einzelbestandteile, vorzugsweise unter Rühren, wurden die erfindungsgemäßen Testlösungen E1 bis E3 sowie die Vergleichslösungen V1 bis V4 gemäß Tabelle 1 hergestellt. Tabelle 1: Testlösungen Einzelbestandteile (Gew. %) (bezogen auf gesamte Lösung) E1 E2 E3 V1 V2 V3 V4 Alkyl-(C8-C14) - polyglucosid (Glucopon® 650) 0,75 0,75 0,5 - 1,6 - - Dimethyl-C8-C18-acylamido-propyl-acetobetain (Dehyton® K) 0,25 0,25 0,2 - - - 1,6 Isotridecyl-fettalkoholethoxylat (8EO) (Lutensol® TO 89) 1,5 1,5 0,9 - - 1,6 - Dimethylalkyl - (C12-C14)-benzylammoniumchlorid - 0,15 - - - - - Glucoprotamin® - 0,05 - - - - - - Lauryldipropylentriamin - - 0,3 0,3 0,3 0,3 0,3 Ethanol (96 Vol.-%) 5,0 5,0 - - - 40,0 - 2-Propanol 25,0 25,0 30,0 40,0 30,0 - - 1-Propanol - - - - - 40,0 Wasser By simply combining different individual constituents, preferably while stirring, the test solutions E1 to E3 according to the invention and the comparative solutions V1 to V4 according to Table 1 were prepared. <b> Table 1: Test Solutions </ b> Individual components (% by weight) (relative to the total solution) E1 E2 E3 V1 V2 V3 V4 Alkyl (C8-C14) - polyglucoside (Glucopon ® 650) 0.75 0.75 0.5 - 1.6 - - Dimethyl-C8-C18-acylamido-propyl acetobetaine (Dehyton ® K) 0.25 0.25 0.2 - - - 1.6 Isotridecyl fatty alcohol ethoxylate (8EO) (Lutensol ® TO 89) 1.5 1.5 0.9 - - 1.6 - Dimethylalkyl (C12-C14) benzylammonium chloride - 0.15 - - - - - Glucoprotamine ® - 0.05 - - - - - - lauryldipropylenetriamine - - 0.3 0.3 0.3 0.3 0.3 Ethanol (96 vol.%) 5.0 5.0 - - - 40.0 - 2-propanol 25.0 25.0 30.0 40.0 30.0 - - 1-propanol - - - - - 40.0 water

2. Prüfung der Wirksamkeit der erfindungsgemäßen Beispiele E1 und E2 gegen das grampositive Bakterium Staphylococcus aureus.2. Testing the effectiveness of the inventive examples E1 and E2 against the Gram-positive bacterium Staphylococcus aureus.

Die Prüfungen zur bakteriziden Wirksamkeit erfolgten im quantitativen Suspensionstest nach den Richtlinien der Deutschen Gesellschaft für Hygiene und Mikrobiologie gegen den Testkeim Staphylococcus aureus mit den unverdünnten Mischungen E1 und E2. Die Ergebnisse sind in Tabelle 2 zusammengefasst. Es zeigt sich, dass die genannten Mischungen zum Teil bereits nach 0,5 Minuten (E2) und insbesondere nach 3 Minuten hervorragend wirken. Tabelle 2: Wirksamkeit der erfindungsgemäßen Beispiele E1 und E2 gegen das grampositive Bakterium Staphylococcus aureus Keimreduktion (log-Stufen) Prüfpräparat 0,5 min 1 min 3 min Mischung E1 < 1,10 1,98 4,82 Mischung E2 > 5,49 > 5,41 > 5,38 The bactericidal effectiveness tests were carried out in a quantitative suspension test according to the guidelines of the German Society for Hygiene and Microbiology against the test bacterium Staphylococcus aureus with the undiluted mixtures E1 and E2. The results are summarized in Table 2. It turns out that some of the above mixtures have an excellent effect already after 0.5 minutes (E2) and in particular after 3 minutes. <b> Table 2: </ b> Effectiveness of the inventive examples E1 and E2 against the Gram-positive bacterium Staphylococcus aureus Germ reduction (log levels) investigational 0.5 min 1 min 3 min Mixture E1 <1,10 1.98 4.82 Mix E2 > 5.49 > 5.41 > 5.38

3. Prüfung des Abtrocknungsverhaltens der erfindungsgemäßen Beispiele E1 und E23. Examination of the drying behavior of the inventive examples E1 and E2

Zur Ermittlung des Abtrocknungsverhaltens auf Oberflächen wurde 0,3 g der Mischungen E1 und E2 mittels einer Schaumsprühvorrichtung auf 100 cm2 Keramikfliesen aufgetragen und der Zeitraum bis zum sichtbaren Abtrocknen der Oberfläche ermittelt.
Die Ergebnisse sind in Tabelle 3 zusammengefasst. Tabelle 3: Abtrocknungsverhalten der erfindungsgemäßen Beispiele E1 und E2 Prüfpräparat Abtrocknungszeit (min) Mischung E1 2,0 Mischung E2 2,5
In order to determine the drying behavior on surfaces, 0.3 g of the mixtures E1 and E2 were applied to 100 cm 2 ceramic tiles by means of a foam spraying device and the period until the visible drying of the surface was determined.
The results are summarized in Table 3. <b> Table 3: </ b> Drying behavior of the inventive examples E1 and E2 investigational Drying time (min) Mixture E1 2.0 Mix E2 2.5

4. Prüfung des Schaumverhaltens der erfindungsgemäßen Beispiele E1 bis E3 im Vergleich zu den Vergleichs-Lösungen V1 bis V44. Testing of the foaming behavior of the inventive examples E1 to E3 in comparison to the comparative solutions V1 to V4

Zur Prüfung des Schaumverhaltens wurden die Mischungen E1 bis E4 und V1 bis V4 mittels einer Gitterschaumsprühvorrichtung auf eine PVC-Oberfläche aufgebracht. Für eine optimale Anwendung sollte, ausgehend von einer klaren Lösung, beim Versprühen ein kräftiger Schaum entstehen, welcher nach dem Aufbringen auf der Oberfläche innerhalb von 1 bis 2 Minuten zerfällt.
Die Ergebnisse sind in Tabelle 4 zusammengefasst.
Es ergibt sich deutlich, dass die erfindungsgemäßen Kombinationen E1 bis E4 hinsichtlich des Schaumverhaltens Vorteile gegenüber den Vergleichsformulierungen V1 bis V4 aufweisen. Tabelle 4: Prüfung des Schaumverhaltens von E1 bis E3 im Vergleich zu V1 bis V4 Prüfparameter Mischung Aussehen der Lösung Konsistenz des Schaumes Stabilität des Schaumes V1 Klar, farblos Dünner Schaum Keine V2 Trüb, milchig Mittlerer Schaum Ca. 3,5 min V3 Klar, farblos Kräftiger Schaum Ca. 30 sek V4 Klar, farblos Dünner Schaum Ca. 5 sek E1 Minimale Trübung, farblos Kräftiger Schaum Ca. 90 sek E2 Minimale Trübung, farblos Kräftiger Schaum ca. 90 sek E3 Klar, farblos Kräftiger Schaum Ca. 90 sek
To test the foam behavior, the mixtures E1 to E4 and V1 to V4 were applied to a PVC surface by means of a lattice foam spray device. For optimal application, starting with a clear solution, a strong foam should form when sprayed, which will disintegrate within 1 to 2 minutes after application to the surface.
The results are summarized in Table 4.
It can be clearly seen that the combinations E1 to E4 according to the invention have advantages over the comparative formulations V1 to V4 with regard to the foaming behavior. <b> Table 4: </ b> Testing the foaming behavior of E1 to E3 compared to V1 to V4 Test parameters mixture Appearance of the solution Consistency of the foam Stability of the foam V1 Clear, colorless Thin foam None V2 Cloudy, milky Medium foam Approximately 3,5 min V3 Clear, colorless Strong foam Approximately 30 sec V4 Clear, colorless Thin foam Approximately 5 sec E1 Minimal haze, colorless Strong foam Approximately 90 sec E2 Minimal haze, colorless Strong foam about 90 sec E3 Clear, colorless Strong foam Approximately 90 sec

Claims (12)

  1. An aqueous foam disinfectant comprising 0.1 to 10wt.-% of a surfactant system of non-ionic and amphoteric surfactants, which system is capable of forming foam upon contact with amines, and a synergistic disinfectant component consisting of an antimicrobial agent with amino groups and at least one additional antimicrobial agent,
    said additional antimicrobial agent being selected from the group of monohydric low-molecular weight alcohols according to formula (IV),
    Figure imgb0003
    wherein R3, R4 and R5 independently comprise H atoms or alkyl residues having 1 to 3 C atoms, the total number of C atoms not being greater than 6,
    said alcohols, or mixtures thereof, constituting a total of 20 to 50 wt.-%, based on the overall disinfectant
  2. The foam disinfectant according to claim 1, characterized in that the non-ionic surfactants are selected from the groups of fatty alcohol ethoxylates and alkylpolyglycosides and the amphoteric surfactants are selected from the group of acetobetaines.
  3. The foam disinfectant according to claim 2, characterized in that the above-mentioned surfactant system comprises at least one surfactant from each of the groups of fatty alcohol ethoxylates, alkylpolyglycosides and acetobetaines.
  4. The foam disinfectant according to claim 3, characterized in that the above-mentioned fatty alcohol ethoxylate, alkylpolyglycoside and acetobetaine groups of surfactants are present at a weight ratio of 5-7 : 2-4 : 0.5-1.5.
  5. The foam disinfectant according to one or more of claims 1 to 4, characterized in that the above-mentioned antimicrobial agent with amino groups constitutes a total of 0.001 to 10 wt.-%, based on the overall disinfectant.
  6. The foam disinfectant according to one or more of claims 1 to 5, characterized in that the above-mentioned antimicrobial agent with amino groups is selected from alkylamines of formulas (I) and/or (II)

            R1-NH-(CH2)3NH2     (I),

            R1-N[(CH2)3NH2]2     (II),

    which can be present in a non-neutralized, partially or completely neutralized form,
    wherein R1 represents an alkyl residue with 8 to 18 C atoms, preferably 12 to 14 C atoms, and/or
    active substances which can be obtained by reacting a propylenediamine in accordance with formula (I),

            R1-NH-(CH2)3NH2     (I),

    with glutamic acid or glutamic acid derivatives in accordance with formula (III),

            R2-O-CO-(CH2)2CH(NH2)-COOH     (III),

    wherein R2 represents hydrogen or an alkyl residue with 1 to 4 carbon atoms, and optionally reacting the product thus obtained with ethylene oxide and/or propylene oxide, and optionally further reacting with organic or inorganic acids.
  7. The foam disinfectant according to one or more of claims 1 to 6, characterized in that the above-mentioned additional antimicrobial agent is further selected from the group of quaternary ammonium compounds.
  8. The foam disinfectant according to one or more of claims 1 to 7, characterized in that the above-mentioned alcohol is selected from ethanol, 1-propanol and 2-propanol.
  9. The foam disinfectant according to one or more of claims 7 or 8, characterized in that the disinfectant, based on the overall disinfectant, includes
    0.005 to 2.0 wt.-% of the above-mentioned antimicrobial agent with amino groups,
    20 to 40 wt.-% of the above-mentioned alcohol,
    0.5 to 5 wt.-% of the above-mentioned surfactant system, as well as
    0 to 2 wt.-% of a quaternary ammonium compound, and
    0 to 6 wt.-% of standard additives such as complexing agents and perfumes.
  10. A method for the foam disinfection of surfaces, characterized in that an aqueous foam disinfectant in accordance with any of claims 1 to 9 is applied on the above-mentioned surfaces in the form of a foam, using a foam-generating device such as a foam spray bottle, and, if desired, the foam is removed by rinsing with water after a sufficient time of exposure.
  11. Use of the foam disinfectants in accordance with any of claims 1 to 9 in the disinfection of surfaces.
  12. The use according to claim 11, characterized in that surfaces are subjected to treatment in the medical sector, in the food producing and/or processing industry, in the hotel business, in public buildings and institutions.
EP03738067A 2002-06-27 2003-06-20 Foam disinfectant Expired - Lifetime EP1516042B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10228656 2002-06-27
DE10228656A DE10228656A1 (en) 2002-06-27 2002-06-27 The foam disinfectant
PCT/EP2003/006498 WO2004003126A1 (en) 2002-06-27 2003-06-20 Foam disinfectant

Publications (2)

Publication Number Publication Date
EP1516042A1 EP1516042A1 (en) 2005-03-23
EP1516042B1 true EP1516042B1 (en) 2006-10-25

Family

ID=29761458

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03738067A Expired - Lifetime EP1516042B1 (en) 2002-06-27 2003-06-20 Foam disinfectant

Country Status (6)

Country Link
US (1) US8097265B2 (en)
EP (1) EP1516042B1 (en)
AT (1) ATE343626T1 (en)
DE (2) DE10228656A1 (en)
PL (1) PL203184B1 (en)
WO (1) WO2004003126A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3015538A1 (en) 2014-11-03 2016-05-04 Wet Wipe A/S Disinfectant and/or cleaning article, use thereof and method for disinfecting and/or cleaning surfaces, tools and/or instruments

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011016452A1 (en) * 2011-04-08 2012-10-11 Bode Chemie Gmbh Disinfectants for screen surfaces of electronic devices
US9920058B2 (en) 2013-05-06 2018-03-20 Georgia Tech Research Corporation Molecules with potent DHFR binding affinity and antibacterial activity
JP6109683B2 (en) * 2013-08-23 2017-04-05 日本曹達株式会社 Foam antibacterial composition
FR3037597B1 (en) 2015-06-16 2019-05-31 Commissariat A L'energie Atomique Et Aux Energies Alternatives AQUEOUS DISINFECTANT FOAM, PROCESS FOR PREPARING SAME AND USES THEREOF
US10653658B2 (en) 2015-08-11 2020-05-19 Akeso Biomedical, Inc. Biofilm inhibiting compositions enhancing weight gain in livestock
WO2017027742A1 (en) 2015-08-11 2017-02-16 Akeso Biomedical, Inc. Biofilm inhibiting compositions enhancing weight gain in livestock
CN109414432B (en) 2016-06-14 2022-03-08 港大科桥有限公司 Antimicrobial compounds and methods of use thereof
CN111093370A (en) * 2017-09-15 2020-05-01 高乔工业股份有限公司 Antimicrobial compositions
WO2019215679A1 (en) 2018-05-10 2019-11-14 Protair-X Health Solutions, Inc. Foam sanitizer composition
EP4227393A1 (en) * 2022-02-11 2023-08-16 The Procter & Gamble Company Cleaning product

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2001317A1 (en) 1970-01-13 1971-07-29 Hans Schade Toothpaste and mouth-wash composition
CH675429A5 (en) 1988-03-18 1990-09-28 Lonza Ag
DE4007758A1 (en) * 1990-03-12 1991-09-19 Henkel Kgaa MEANS AND METHODS FOR CLEANING AND DISINFECTING OBJECTS FROM MEDICAL EQUIPMENT IN AUTOMATED EQUIPMENT
DE4234070A1 (en) * 1992-10-09 1994-04-14 Henkel Ecolab Gmbh & Co Ohg Cleaning disinfectant
US5635469A (en) * 1993-06-10 1997-06-03 The Procter & Gamble Company Foaming cleansing products
FR2708278B1 (en) * 1993-06-28 1995-09-08 Paragerm Snc Cleaning and disinfecting composition for hospitals.
US5576284A (en) * 1994-09-26 1996-11-19 Henkel Kommanditgesellschaft Auf Aktien Disinfecting cleanser for hard surfaces
CA2224798A1 (en) * 1995-06-22 1997-01-09 Matthew T. Scholz Stable hydroalcoholic compositions
DE19615286B4 (en) * 1996-04-18 2005-05-19 Cognis Deutschland Gmbh & Co. Kg Antimicrobial active ingredient concentrates
DE19652680A1 (en) * 1996-12-18 1998-06-25 Clariant Gmbh Mixtures of alkoxylates with foam-suppressing and disinfecting effects and their use in cleaning agents
CO5040174A1 (en) * 1997-12-12 2001-05-29 Colgate Palmolive Co ANTIMICROBIAL COMPOSITIONS FOR MULTIPLE MICROEMULSION PURPOSES CONTAINING A CATIONIC TENSIOACTIVE
US6140289A (en) * 2000-01-24 2000-10-31 Colgate-Palmolive Company Antimicrobial cleaning composition containing a cationic surfactant
US20040200725A1 (en) * 2003-04-09 2004-10-14 Applied Materials Inc. Application of antifoaming agent to reduce defects in a semiconductor electrochemical plating process

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3015538A1 (en) 2014-11-03 2016-05-04 Wet Wipe A/S Disinfectant and/or cleaning article, use thereof and method for disinfecting and/or cleaning surfaces, tools and/or instruments

Also Published As

Publication number Publication date
US20100111877A1 (en) 2010-05-06
PL374357A1 (en) 2005-10-17
DE10228656A1 (en) 2004-01-22
WO2004003126A1 (en) 2004-01-08
DE50305504D1 (en) 2006-12-07
US8097265B2 (en) 2012-01-17
PL203184B1 (en) 2009-09-30
EP1516042A1 (en) 2005-03-23
ATE343626T1 (en) 2006-11-15

Similar Documents

Publication Publication Date Title
EP1322156B3 (en) Disinfectant
EP0551975B1 (en) Disinfectant concentrate and disinfectant based on amines and alcohols and use thereof
WO1998047993A1 (en) Liquid enzyme preparation and the use thereof
DE4005784C2 (en) Disinfectant concentrate and its use as a mycobactericide and virucide
EP1516042B1 (en) Foam disinfectant
EP1277403B1 (en) Disinfectant concentrate based on quaternary ammonium compounds and its use for automated instrument disinfection
EP0612470B1 (en) Disinfecting agent concentrate and disinfecting agent on amin- and alcohol basis and use thereof
EP1137338A1 (en) Disinfecting agents
DE19801821B4 (en) Tuberculocidal disinfectant
DE10040664B4 (en) Disinfectant concentrates and their use for mechanical instrument disinfection
DE102015122276A1 (en) Alcoholic compositions containing octenidine dihydrochloride
DE102015113641A1 (en) Disinfectant with organic acids
DE3333443A1 (en) DISINFECTANT CONCENTRATES BASED ON SHORT-CHAIN FATTY ACIDS
EP1458239B1 (en) Fungicidal compositions of disinfecting and preserving agents
EP0385369B1 (en) Method for the antimicrobiol preservation of surfactant
EP1627646A1 (en) Cleaning and disinfecting agent for medical instruments with improved effectiveness against Hepatitis B Virus
EP3542628A1 (en) Disinfectant and use of n,n-bis(3-aminopropyl) alkylamine in disinfectant
DE4217690C1 (en) Disinfectant for use in animal stalls - contains aldehyde(s), alkyl:alkanol(s) and phenoxy:alkanol(s)
DE10310377A1 (en) Disinfectant concentrates based on quaternary ammonium compounds as well as their use for chemothermal instrument reprocessing
DE19749964B4 (en) Washing solution for the beverage and food industry
EP1362512B1 (en) Aqueous disinfectant based on alkylamines and aminopolycarboxylic acids
EP1031280B1 (en) Concentrate of disinfecting agent
DE202020105154U1 (en) Fully biodegradable biocide
EP1035195A1 (en) Fragrant composition, especially suitable as toilet freshener

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20041119

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: C11D 1/94 20060101ALI20060420BHEP

Ipc: C11D 3/48 20060101AFI20060420BHEP

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20061025

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061025

Ref country code: IE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061025

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061025

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061025

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061025

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061025

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061025

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REF Corresponds to:

Ref document number: 50305504

Country of ref document: DE

Date of ref document: 20061207

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070125

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070125

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070125

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070205

GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 20070117

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070326

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
ET Fr: translation filed
REG Reference to a national code

Ref country code: IE

Ref legal event code: FD4D

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20070726

BERE Be: lapsed

Owner name: ECOLAB INC.

Effective date: 20070630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070630

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070126

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070630

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070620

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061025

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061025

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070620

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061025

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070426

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 50305504

Country of ref document: DE

Representative=s name: GODEMEYER BLUM LENZE PARTNERSCHAFT, PATENTANWA, DE

Ref country code: DE

Ref legal event code: R082

Ref document number: 50305504

Country of ref document: DE

Representative=s name: GODEMEYER BLUM LENZE PATENTANWAELTE, PARTNERSC, DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 13

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 14

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 15

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20220428

Year of fee payment: 20

Ref country code: FR

Payment date: 20220510

Year of fee payment: 20

Ref country code: DE

Payment date: 20220427

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 50305504

Country of ref document: DE

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20230619

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20230619